[SCHEDULE 13G/A] Context Therapeutics Inc. SEC Filing
Avidity Partners and affiliated funds filed a Schedule 13G reporting significant passive holdings in Context Therapeutics Inc. The filing discloses that certain Avidity reporting persons hold shared voting and shared dispositive power over 9,126,176 shares, representing approximately 9.9% of the outstanding common stock. Individual fund positions reported in the filing include Avidity Master Fund LP with 5,183,700 shares (5.6%) and Avidity Private Master Fund I LP with 7,776,296 shares (8.4%). Michael Gregory is listed among the reporting persons with the same shared power totaling 9,126,176 shares.
The filing indicates no sole voting or dispositive power for any reporting person and includes a certification that the securities were not acquired to change or influence control of the issuer. Exhibits referenced in the filing include a Joint Filing Agreement and Control Person Identification.
Avidity Partners e fondi affiliati hanno depositato uno Schedule 13G che segnala rilevanti partecipazioni passive in Context Therapeutics Inc. Il documento rivela che alcune persone che agiscono per conto di Avidity detengono congiuntamente il potere di voto e il potere dispositvo su 9.126.176 azioni, pari a circa il 9,9% del capitale sociale ordinario in circolazione. Le posizioni dei singoli fondi riportate includono Avidity Master Fund LP con 5.183.700 azioni (5,6%) e Avidity Private Master Fund I LP con 7.776.296 azioni (8,4%). Michael Gregory risulta fra le persone segnalanti con lo stesso potere condiviso, per un totale di 9.126.176 azioni.
Il deposito specifica che nessuna persona segnalante detiene potere di voto o potere dispositvo esclusivo e contiene una certificazione che i titoli non sono stati acquisiti allo scopo di modificare o influenzare il controllo dell'emittente. Gli allegati citati comprendono un accordo di deposito congiunto (Joint Filing Agreement) e l'identificazione della persona di controllo.
Avidity Partners y fondos afiliados presentaron un Schedule 13G que reporta participaciones pasivas significativas en Context Therapeutics Inc. La presentaci贸n revela que ciertas personas informantes de Avidity poseen conjuntamente el poder de voto y el poder de disposici贸n sobre 9.126.176 acciones, que representan aproximadamente el 9,9% del capital social ordinario en circulaci贸n. Las posiciones individuales de fondos incluidas en el informe son Avidity Master Fund LP con 5.183.700 acciones (5,6%) y Avidity Private Master Fund I LP con 7.776.296 acciones (8,4%). Michael Gregory figura entre las personas informantes con el mismo poder compartido que suma 9.126.176 acciones.
La presentaci贸n indica que ninguna persona informante tiene poder de voto ni poder de disposici贸n exclusivo e incluye una certificaci贸n de que los valores no fueron adquiridos para cambiar o influir en el control del emisor. Los anexos mencionados incluyen un acuerdo de presentaci贸n conjunta (Joint Filing Agreement) y la identificaci贸n de la persona de control.
Avidity Partners 氚� 瓿勳棿 韼�霌滉皜 Context Therapeutics Inc.鞐� 雽�頃� 靸侂嫻頃� 靾橂彊鞝� 氤挫湢毳� 氤搓碃頃橂姅 Schedule 13G毳� 鞝滌稖頄堨姷雼堧嫟. 鞝滌稖靹滊鞐� 霐半ゴ氅� 鞚茧秬 Avidity 氤搓碃鞚胳潃 瓿惦彊 鞚橁舶甓岅臣 瓿惦彊 觳橂秳甓岇潉 韱淀暣 9,126,176欤�毳� 氤挫湢頃橁碃 鞛堨溂氅�, 鞚措姅 氚滍枆 氤错喌欤检潣 鞎� 9.9%鞐� 頃措嫻頃╇媹雼�. 氤搓碃靹滌棎 旮办灛霅� 臧滊硠 韼�霌� 氤挫湢 雮挫棴鞙茧電� Avidity Master Fund LP 5,183,700欤�(5.6%)鞕赌 Avidity Private Master Fund I LP 7,776,296欤�(8.4%)臧� 韽暔霅橃柎 鞛堨姷雼堧嫟. Michael Gregory霃� 齑� 9,126,176欤检棎 雽�頃� 霃欖澕頃� 瓿惦彊 甓岉暅鞚� 臧�歆� 氤搓碃鞚胳溂搿� 霌膘灛霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 鞝滌稖靹滊電� 鞏措枻 氤搓碃鞚鸽弰 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潉 氤挫湢頃橃 鞎婋姅雼�瓿� 氇呾嫓頃橂┌, 鞚� 歃濌秾霌れ澊 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞙茧 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 鞚胳頃橂姅 雮挫毄鞚� 韽暔頃╇媹雼�. 鞝滌稖靹滊鞚� 觳秬氍茧電� 瓿惦彊 鞝滌稖 瓿勳暯靹�(Joint Filing Agreement)鞕赌 歆�氚办澑(旎姼搿� 韻检姩) 鞁濍硠 靹滊臧� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Avidity Partners et des fonds affili茅s ont d茅pos茅 un Schedule 13G d茅clarant des participations passives significatives dans Context Therapeutics Inc. Le d茅p么t indique que certaines personnes d茅clarante d'Avidity d茅tiennent conjointement le pouvoir de vote et le pouvoir de disposition sur 9 126 176 actions, repr茅sentant environ 9,9 % du capital social ordinaire en circulation. Les positions individuelles des fonds mentionn茅es comprennent Avidity Master Fund LP avec 5 183 700 actions (5,6 %) et Avidity Private Master Fund I LP avec 7 776 296 actions (8,4 %). Michael Gregory figure parmi les d茅clarants avec le m锚me pouvoir partag茅, pour un total de 9 126 176 actions.
Le d茅p么t pr茅cise qu'aucun d茅clarant ne d茅tient de pouvoir de vote ou de disposition exclusif et inclut une attestation que les titres n'ont pas 茅t茅 acquis dans le but de modifier ou d'influencer le contr么le de l'茅metteur. Les annexes mentionn茅es comprennent un accord de d茅p么t conjoint (Joint Filing Agreement) et l'identification de la personne de contr么le.
Avidity Partners und verbundene Fonds haben ein Schedule 13G eingereicht, das wesentliche passive Beteiligungen an Context Therapeutics Inc. meldet. Die Einreichung zeigt, dass bestimmte meldende Personen von Avidity gemeinsames Stimm- und Verf眉gungsrecht 眉ber 9.126.176 Aktien innehaben, was etwa 9,9% des ausstehenden Stammkapitals entspricht. In der Meldung aufgef眉hrte Einzelpositionen der Fonds umfassen Avidity Master Fund LP mit 5.183.700 Aktien (5,6%) und Avidity Private Master Fund I LP mit 7.776.296 Aktien (8,4%). Michael Gregory ist als meldende Person mit demselben gemeinsamen Recht f眉r insgesamt 9.126.176 Aktien genannt.
Die Einreichung stellt klar, dass keine meldende Person alleinige Stimm- oder Verf眉gungsgewalt besitzt, und enth盲lt eine Best盲tigung, dass die Wertpapiere nicht erworben wurden, um die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen. Als Anlagen werden ein Vereinbarung zur gemeinsamen Einreichung (Joint Filing Agreement) und die Identifikation der Kontrollperson genannt.
- Reported beneficial ownership of 9,126,176 shares representing 9.9% of Context Therapeutics common stock.
- Detailed fund-level positions disclosed, including 5,183,700 shares (5.6%) for Avidity Master Fund LP and 7,776,296 shares (8.4%) for Avidity Private Master Fund I LP.
- Filed Schedule 13G with a certification of passive intent and included exhibits (Joint Filing Agreement and Control Person Identification) as part of the disclosure.
- None.
Insights
TL;DR: Avidity reports a material passive stake of 9.9% in CNTX with shared voting/dispositive power; this is a notable ownership disclosure for investors.
The Schedule 13G shows Avidity-affiliated entities collectively holding 9,126,176 shares (9.9%) of Context Therapeutics common stock and reporting only shared voting and dispositive powers. The filing is a passive disclosure rather than an active 13D claim, and it includes a formal certification that the holdings were not acquired to influence control. For investors, the key facts are the size of the position and the coordinated reporting across multiple Avidity entities, both explicitly stated in the filing.
TL;DR: Coordinated Avidity ownership is disclosed as passive (Schedule 13G) with shared powers; governance impact is limited absent additional actions.
The filing documents shared voting and dispositive power across several Avidity entities rather than any sole control. Reported fund-level holdings include 5,183,700 shares (5.6%) for Avidity Master Fund LP and 7,776,296 shares (8.4%) for Avidity Private Master Fund I LP, with aggregate shared power of 9,126,176 shares (9.9%). The report includes a certification stating the securities were not acquired to change or influence control and attaches a Joint Filing Agreement and Control Person Identification exhibit, all as stated in the document.
Avidity Partners e fondi affiliati hanno depositato uno Schedule 13G che segnala rilevanti partecipazioni passive in Context Therapeutics Inc. Il documento rivela che alcune persone che agiscono per conto di Avidity detengono congiuntamente il potere di voto e il potere dispositvo su 9.126.176 azioni, pari a circa il 9,9% del capitale sociale ordinario in circolazione. Le posizioni dei singoli fondi riportate includono Avidity Master Fund LP con 5.183.700 azioni (5,6%) e Avidity Private Master Fund I LP con 7.776.296 azioni (8,4%). Michael Gregory risulta fra le persone segnalanti con lo stesso potere condiviso, per un totale di 9.126.176 azioni.
Il deposito specifica che nessuna persona segnalante detiene potere di voto o potere dispositvo esclusivo e contiene una certificazione che i titoli non sono stati acquisiti allo scopo di modificare o influenzare il controllo dell'emittente. Gli allegati citati comprendono un accordo di deposito congiunto (Joint Filing Agreement) e l'identificazione della persona di controllo.
Avidity Partners y fondos afiliados presentaron un Schedule 13G que reporta participaciones pasivas significativas en Context Therapeutics Inc. La presentaci贸n revela que ciertas personas informantes de Avidity poseen conjuntamente el poder de voto y el poder de disposici贸n sobre 9.126.176 acciones, que representan aproximadamente el 9,9% del capital social ordinario en circulaci贸n. Las posiciones individuales de fondos incluidas en el informe son Avidity Master Fund LP con 5.183.700 acciones (5,6%) y Avidity Private Master Fund I LP con 7.776.296 acciones (8,4%). Michael Gregory figura entre las personas informantes con el mismo poder compartido que suma 9.126.176 acciones.
La presentaci贸n indica que ninguna persona informante tiene poder de voto ni poder de disposici贸n exclusivo e incluye una certificaci贸n de que los valores no fueron adquiridos para cambiar o influir en el control del emisor. Los anexos mencionados incluyen un acuerdo de presentaci贸n conjunta (Joint Filing Agreement) y la identificaci贸n de la persona de control.
Avidity Partners 氚� 瓿勳棿 韼�霌滉皜 Context Therapeutics Inc.鞐� 雽�頃� 靸侂嫻頃� 靾橂彊鞝� 氤挫湢毳� 氤搓碃頃橂姅 Schedule 13G毳� 鞝滌稖頄堨姷雼堧嫟. 鞝滌稖靹滊鞐� 霐半ゴ氅� 鞚茧秬 Avidity 氤搓碃鞚胳潃 瓿惦彊 鞚橁舶甓岅臣 瓿惦彊 觳橂秳甓岇潉 韱淀暣 9,126,176欤�毳� 氤挫湢頃橁碃 鞛堨溂氅�, 鞚措姅 氚滍枆 氤错喌欤检潣 鞎� 9.9%鞐� 頃措嫻頃╇媹雼�. 氤搓碃靹滌棎 旮办灛霅� 臧滊硠 韼�霌� 氤挫湢 雮挫棴鞙茧電� Avidity Master Fund LP 5,183,700欤�(5.6%)鞕赌 Avidity Private Master Fund I LP 7,776,296欤�(8.4%)臧� 韽暔霅橃柎 鞛堨姷雼堧嫟. Michael Gregory霃� 齑� 9,126,176欤检棎 雽�頃� 霃欖澕頃� 瓿惦彊 甓岉暅鞚� 臧�歆� 氤搓碃鞚胳溂搿� 霌膘灛霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 鞝滌稖靹滊電� 鞏措枻 氤搓碃鞚鸽弰 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潉 氤挫湢頃橃 鞎婋姅雼�瓿� 氇呾嫓頃橂┌, 鞚� 歃濌秾霌れ澊 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞙茧 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 鞚胳頃橂姅 雮挫毄鞚� 韽暔頃╇媹雼�. 鞝滌稖靹滊鞚� 觳秬氍茧電� 瓿惦彊 鞝滌稖 瓿勳暯靹�(Joint Filing Agreement)鞕赌 歆�氚办澑(旎姼搿� 韻检姩) 鞁濍硠 靹滊臧� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Avidity Partners et des fonds affili茅s ont d茅pos茅 un Schedule 13G d茅clarant des participations passives significatives dans Context Therapeutics Inc. Le d茅p么t indique que certaines personnes d茅clarante d'Avidity d茅tiennent conjointement le pouvoir de vote et le pouvoir de disposition sur 9 126 176 actions, repr茅sentant environ 9,9 % du capital social ordinaire en circulation. Les positions individuelles des fonds mentionn茅es comprennent Avidity Master Fund LP avec 5 183 700 actions (5,6 %) et Avidity Private Master Fund I LP avec 7 776 296 actions (8,4 %). Michael Gregory figure parmi les d茅clarants avec le m锚me pouvoir partag茅, pour un total de 9 126 176 actions.
Le d茅p么t pr茅cise qu'aucun d茅clarant ne d茅tient de pouvoir de vote ou de disposition exclusif et inclut une attestation que les titres n'ont pas 茅t茅 acquis dans le but de modifier ou d'influencer le contr么le de l'茅metteur. Les annexes mentionn茅es comprennent un accord de d茅p么t conjoint (Joint Filing Agreement) et l'identification de la personne de contr么le.
Avidity Partners und verbundene Fonds haben ein Schedule 13G eingereicht, das wesentliche passive Beteiligungen an Context Therapeutics Inc. meldet. Die Einreichung zeigt, dass bestimmte meldende Personen von Avidity gemeinsames Stimm- und Verf眉gungsrecht 眉ber 9.126.176 Aktien innehaben, was etwa 9,9% des ausstehenden Stammkapitals entspricht. In der Meldung aufgef眉hrte Einzelpositionen der Fonds umfassen Avidity Master Fund LP mit 5.183.700 Aktien (5,6%) und Avidity Private Master Fund I LP mit 7.776.296 Aktien (8,4%). Michael Gregory ist als meldende Person mit demselben gemeinsamen Recht f眉r insgesamt 9.126.176 Aktien genannt.
Die Einreichung stellt klar, dass keine meldende Person alleinige Stimm- oder Verf眉gungsgewalt besitzt, und enth盲lt eine Best盲tigung, dass die Wertpapiere nicht erworben wurden, um die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen. Als Anlagen werden ein Vereinbarung zur gemeinsamen Einreichung (Joint Filing Agreement) und die Identifikation der Kontrollperson genannt.
FAQ
How many shares of CNTX does Avidity beneficially own?
What percentage of CNTX common stock does Avidity report owning?
Do any reporting persons have sole voting or dispositive power over the shares?
Which Avidity funds are specifically identified and what are their reported holdings?
Does the filing state intent to influence control of Context Therapeutics (CNTX)?
